Sana Biotechnology, Inc. Earnings Per Share (Basic)
Sana Biotechnology, Inc. (SANA) reported Earnings Per Share (Basic) of -$0.22 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- Sana Biotechnology, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.22.
- Sana Biotechnology, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.17.
- Sana Biotechnology, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.16.
- Sana Biotechnology, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.39.
- Sana Biotechnology, Inc. earnings per share, basic for fiscal 2025 was -$0.96.
- Sana Biotechnology, Inc. earnings per share, basic for fiscal 2024 was -$1.16.
- Sana Biotechnology, Inc. earnings per share, basic for fiscal 2023 was -$1.46.
- Sana Biotechnology, Inc. earnings per share, basic for fiscal 2022 was -$1.43.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.22 10-Q · filed 2026-08-10 | -$0.39 10-Q · filed 2026-08-10 | ||
| 2026-03-31 | -$0.17 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | -$0.96 10-K · filed 2026-03-03 | |||
| 2025-09-30 | -$0.16 10-Q · filed 2025-11-06 | -$0.75 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$0.39 10-Q · filed 2026-08-10 | -$0.60 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | -$0.21 10-Q · filed 2026-05-11 | |||
| 2024-12-31 | -$1.16 10-K · filed 2026-03-03 | |||
| 2024-09-30 | -$0.25 10-Q · filed 2025-11-06 | -$0.95 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$0.21 10-Q · filed 2025-08-11 | -$0.70 10-Q · filed 2025-08-11 | ||
| 2024-03-31 | -$0.49 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$1.46 10-K · filed 2026-03-03 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | -$1.01 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | -$0.59 10-Q · filed 2024-08-08 | -$1.02 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$0.43 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$1.43 10-K · filed 2025-03-17 | |||
| 2022-09-30 | -$0.45 10-Q · filed 2023-11-08 | -$0.84 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.01 10-Q · filed 2023-11-08 | |
| 2022-06-30 | -$0.39 10-Q · filed 2023-08-03 | -$0.56 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$0.17 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | -$2.14 10-K · filed 2024-02-29 | |||
| 2021-09-30 | -$0.46 10-Q · filed 2022-11-02 | -$1.53 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $0.10 10-Q · filed 2022-08-04 | -$1.08 10-Q · filed 2022-08-04 | ||
| 2020-12-31 | -$21.92 10-K · filed 2023-03-16 | |||
| 2020-06-30 | -$7.18 10-Q · filed 2021-08-04 | -$10.47 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |